Sarl Cpcm Pharmaceutical Import Profile — Algeria (DGFT 2022–2026)

Name: Sarl Cpcm Pharmaceutical Import Records from India — 2 Products, $400.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Sarl Cpcm — Pharmaceutical Importer Profile (2026) | 2 Products, $400.0K Trade | TransData Nexus

Sarl Cpcm

Pharmaceutical Importer · Algeria · Antimalarial & Antiparasitic Focus · $400.0K Total Trade · DGFT Verified

Sarl Cpcm is a pharmaceutical importer based in Algeria with a total trade value of $400.0K across 2 products in 1 therapeutic categories. Based on 8 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Sarl Cpcm sources from 2 verified Indian suppliers, with Zydus Lifesciences Limited accounting for 74.9% of imports.

Sarl Cpcm — Import Portfolio & Supplier Network

Sarl Cpcm import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Sarl Cpcm?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Zydus Lifesciences Limited	$213.0K	6	74.9%
Medopharm	$71.3K	2	25.1%

Sarl Cpcm sources from 2 verified Indian suppliers across 7 distinct formulations.

What Formulations Does Sarl Cpcm Import?

Formulation	Value	Ships
Hydroxychloroquine sulphate 200 MG granules hydroxychloroquine sulfate b nog300160 mfg dt 01 2023 exp dt 12	$100.0K	2
Prednisolone direct compresion	$50.0K	1
Hydroxychloroquine sulphate 200 MG	$50.0K	1
Hydroxychloroquine sulphate 200 MG granules (hydroxychloroquine sulfate tabs usp200mg)	$50.0K	1
Digoxin tablets BP 0.25MG	$21.3K	1
Paraxotine 20MG granules paroxetine b no g203120 mfg dt 11 2022 exp dt 10	$6.5K	1
Paroxetine 20MG granules (paroxetine)	$6.4K	1

Sarl Cpcm imports 7 distinct pharmaceutical formulations. Showing top 7 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Chloroquine	Antimalarial & Antiparasitic	$200.0K	4	0.1%	13
2	Hydroxychloroquine	Antimalarial & Antiparasitic	$200.0K	4	0.1%	9

Sarl Cpcm imports 2 pharmaceutical products across 1 categories into Algeria totaling $400.0K.

Sarl Cpcm — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Sarl Chimie Pharmacie Commerce Multiple (CPCM) is a private limited liability company based in Bordj El Bahri, Wilaya d'Alger, Algeria. Established on August 5, 1997, with a capital of 462 million Algerian Dinars, CPCM specializes in the pharmaceutical industry, focusing on the manufacturing of pharmaceutical products. The company operates as a pharmaceutical importer and buyer, playing a significant role in Algeria's pharmaceutical distribution network by sourcing and supplying essential medicines to meet local demand.

2Distribution Network

CPCM's distribution network is centered in Bordj El Bahri, a suburb of Algiers, which serves as its primary operational hub. While specific details about additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in the capital region suggests a focus on efficient distribution within Algeria. The extent of its geographic coverage beyond Bordj El Bahri is not specified, indicating that CPCM's operations may be primarily concentrated within the national market.

3Industry Role

In Algeria's pharmaceutical supply chain, CPCM functions as a pharmaceutical importer and buyer, sourcing finished pharmaceutical formulations from international suppliers, particularly from India. By importing essential medicines, CPCM contributes to the availability of critical healthcare products in the Algerian market, thereby supporting the national healthcare system's needs.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Sarl Cpcm

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

CPCM's sourcing strategy exhibits a high degree of concentration, with a total import value of $400,000 USD from India over eight shipments, all comprising two products: Chloroquine and Hydroxychloroquine. This indicates a reliance on a limited number of products and suppliers, which could pose risks such as supply chain disruptions or regulatory changes affecting these specific medicines. The shipment data reveals that CPCM has engaged with two Indian suppliers: Zydus Lifesciences Limited, accounting for 74.9% of the shipments, and Medopharm, comprising 25.1%. This suggests a stable relationship with these suppliers, though the lack of diversification in product offerings may limit CPCM's ability to adapt to changing market demands or regulatory environments.

2Supply Chain Resilience

CPCM's supply chain resilience appears limited due to its concentrated sourcing strategy. The company's dependence on two suppliers for a narrow range of products may expose it to risks associated with supply chain disruptions, such as production delays, quality issues, or geopolitical factors affecting trade routes. The absence of backup suppliers and limited formulation diversity further exacerbate this vulnerability. Additionally, the specific shipping routes and regulatory compliance statuses of the key suppliers are not detailed, making it challenging to assess the full extent of potential risks.

Importing Pharmaceuticals into Algeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Algeria

1Regulatory Authority & Framework

The Ministry of the Pharmaceutical Industry is the primary regulatory authority overseeing pharmaceutical imports in Algeria. Key legislation governing these imports includes Decree No. 24, issued on October 1, 2025, which outlines the requirements, procedures, and compliance obligations for licensing pharmaceutical import establishments. This decree modernizes the application process and strengthens oversight of pharmaceutical import activities, replacing the previous decree from December 20, 2021. The National Agency for Pharmaceutical Products (ANPP) is responsible for drug registration and medical device approval, ensuring that imported products meet national standards. (miph.gov.dz)

2Import Licensing & GMP

Import licensing requirements in Algeria are governed by Decree No. 24, which stipulates that pharmaceutical import establishments must obtain authorization from the Ministry of the Pharmaceutical Industry. This process involves submitting an application file containing specific documents, undergoing inspections, and adhering to compliance obligations. The decree also defines the procedures for substantial modifications, renewal, and withdrawal of authorizations. Regarding Good Manufacturing Practice (GMP) certification, Algeria recognizes standards such as EU GMP, WHO GMP, and PIC/S. Importers must ensure that their suppliers hold valid GMP certificates from recognized authorities to comply with Algerian regulations.

Sarl Cpcm — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

CPCM's focus on importing Chloroquine and Hydroxychloroquine suggests a strategic emphasis on antimalarial and antiparasitic treatments. This focus aligns with the therapeutic needs of Algeria, where malaria remains a public health concern. The market demand for these products is driven by the prevalence of malaria and the necessity for effective treatment options. By concentrating on these therapeutic areas, CPCM aims to address critical health challenges and fulfill a vital role in the healthcare system.

2Sourcing Profile

CPCM's sourcing strategy is centered on generic drugs, specifically Chloroquine and Hydroxychloroquine, sourced from India. The company imports finished pharmaceutical formulations, indicating a preference for ready-to-use products that meet Algerian regulatory standards. India's established pharmaceutical manufacturing capabilities and competitive pricing make it a suitable partner for CPCM's procurement needs. This sourcing approach allows CPCM to provide essential medicines efficiently and cost-effectively.

3Market Positioning

Based on its product mix, CPCM serves the Algerian market segment that requires antimalarial and antiparasitic treatments. This includes retail pharmacies, hospitals, and government health programs that address malaria and related diseases. By focusing on these critical therapeutic areas, CPCM positions itself as a key supplier of essential medicines, contributing to the overall health and well-being of the population.

Seller's Guide — How to Become a Supplier to Sarl Cpcm

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with CPCM by offering a broader range of pharmaceutical products, particularly in the antimalarial and antiparasitic categories. Diversifying CPCM's supplier base and product offerings could enhance its supply chain resilience and market competitiveness. Identifying and addressing gaps in CPCM's current sourcing strategy presents a strategic opportunity for Indian exporters to establish partnerships and expand their market presence in Algeria.

2Requirements & Qualifications

Indian exporters seeking to supply CPCM and the Algerian market must ensure that their products comply with Algerian regulations, including obtaining necessary import licenses and adhering to GMP standards recognized by Algerian authorities. Products must undergo batch testing, meet stability requirements, and have labeling in Arabic and French. Additionally, compliance with serialization mandates may be required to ensure product traceability and prevent counterfeiting.

3How to Approach

Frequently Asked Questions — Sarl Cpcm

What products does Sarl Cpcm import from India?

Sarl Cpcm imports 2 pharmaceutical products across 1 categories. Top imports: Chloroquine ($200.0K), Hydroxychloroquine ($200.0K).

Who supplies pharmaceuticals to Sarl Cpcm from India?

Sarl Cpcm sources from 2 verified Indian suppliers. The primary supplier is Zydus Lifesciences Limited (74.9% of imports, $213.0K).

What is Sarl Cpcm's total pharmaceutical import value?

Sarl Cpcm's total pharmaceutical import value from India is $400.0K, based on 8 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Sarl Cpcm focus on?

Sarl Cpcm imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Sarl Cpcm Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.